Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3 in the Study Record, reflecting a minor metadata update; no study content or eligibility criteria are changed.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects an updated version of the study record.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now indicates that recruitment has ended for participants. It also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and makes a formatting adjustment to the Intervention/Treatment header.SummaryDifference0.3%

- Check34 days agoChange DetectedThe page revision label was updated to v3.5.5, indicating a small system or CMS update; no study text or data is changed.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a maintenance update to the study entry without changing its substantive details.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now shows a newer ClinicalTrials.gov “Revision” version (v3.5.3) instead of the previous one (v3.5.2), reflecting an administrative/site update rather than a change to the trial record.SummaryDifference0.0%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.